PDF
Use of Measles-Mumps-Rubella (MMR) Vaccine for the Management of Mumps Outbreaks in Canada
Organization: Public Health Agency of Canada (PHAC)Published: 2021
"The primary objective of this statement is to review the evidence on the effectiveness and safety of additional dose(s) of MMR vaccine when provided in mumps outbreak settings, including the off-label administration of a third dose of MMR vaccine (MMR3) in individuals who were previously vaccinated with two valid doses. A literature and environmental evidence review was undertaken to develop recommendations for the use of additional dose(s) of MMR vaccine in mumps outbreak settings." - Public Health Agency of Canada
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Outbreak and Crisis Management
Outbreak and Pandemic Planning
Vaccine Preventable Diseases
Communicable Diseases
Measles
Mumps
Rubella
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Outbreak and Crisis Management,Outbreak and Pandemic Planning,Vaccine Preventable Diseases,Communicable Diseases,Measles,Mumps,Rubella,Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Outbreak and Crisis Management
Outbreak and Pandemic Planning
Vaccine Preventable Diseases
Communicable Diseases
Measles
Mumps
Rubella
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Audience:
Health Care Professional
Population: Children (All)
Adolescents
Adults
Pregnant and Breastfeeding People
New and Recent Canadians
Healthcare Personnel
Region: National
Population: Children (All)
Adolescents
Adults
Pregnant and Breastfeeding People
New and Recent Canadians
Healthcare Personnel
Region: National
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.